Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

    Patient-derived organoids (PDOs) are valuable in predicting response to cancer therapy. PDOs are ideal models for precision oncologists. However, their practical application in guiding timely clinical decision...

    Sang-Hyun Lee, Kyuhwan Kim, Eunyoung Lee, Kyungmin Lee in npj Precision Oncology (2024)

  2. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses

    The Orthopoxvirus genus, especially variola virus (VARV), monkeypox virus (MPXV), remains a significant public health threat worldwide. The development of therapeutic antibodies against orthopoxviruses is largely...

    Hang Chi, Suo-Qun Zhao, Ru-Yi Chen in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)

    A lasting imbalance between fatty acid synthesis and consumption leads to non-alcoholic fatty liver disease (NAFLD), coupled with hepatitis and insulin resistance. Yet the details of the underlying mechanisms ...

    Lei Zhang, Jiabing Chen, **aoying Yang in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Radiomic texture analysis based on neurite orientation dispersion and density imaging to differentiate glioblastoma from solitary brain metastasis

    We created discriminative models of different regions of interest (ROIs) using radiomic texture features of neurite orientation dispersion and density imaging (NODDI) and evaluated the feasibility of each mode...

    Jie Bai, Mengyang He, Eryuan Gao, Guang Yang, Hongxi Yang, Jie Dong in BMC Cancer (2023)

  6. Article

    Open Access

    Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy

    Clonal hematopoiesis (CH) frequently progresses after chemotherapy or radiotherapy. We evaluated the clinical impact of preoperative CH on the survival outcomes of patients with non-small cell lung cancer (NSC...

    Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim in Genome Medicine (2023)

  7. Article

    Open Access

    A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis

    The objective of this study was to estimate the accuracy of transcriptome-based classifier in differential diagnosis of uterine leiomyoma and leiomyosarcoma. We manually selected 114 normal uterine tissue and ...

    Kidong Kim, Sarah Kim, Tae** Ahn, Hyo** Kim, So-** Shin, Chel Hun Choi in BMC Cancer (2023)

  8. Article

    Open Access

    Effect of serum lactate dehydrogenase-to-albumin ratio (LAR) on the short-term outcomes and long-term prognosis of colorectal cancer after radical surgery

    Whether serum lactate dehydrogenase-to-albumin ratio (LAR) influenced the outcomes of colorectal cancer (CRC) patients after radical surgery remained unclear. Therefore, this study sought to examine how LAR in...

    **n-Peng Shu, Ying-Chun **ang, Fei Liu, Yong Cheng, Wei Zhang, Dong Peng in BMC Cancer (2023)

  9. Article

    Open Access

    MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

    Non-coding microRNAs (miRNAs) play critical roles in tumor progression and hold great promise as therapeutic agents for multiple cancers. MicroRNA 29a (miR-29a) is a tumor suppressor miRNA that inhibits cancer...

    Seung-Myoung Son, Jieun Yun, Dong-Wook Kim, Young-Suk Jung, Sang-Bae Han in BMC Cancer (2023)

  10. Article

    Open Access

    Clinical implications of micro lymph node metastasis for patients with gastric cancer

    Lymph node size is considered as a criterion for possible lymph node metastasis in imageology. Micro lymph nodes are easily overlooked by surgeons and pathologists. This study investigated the influencing fact...

    Yuan Tian, Yue Pang, Pei-Gang Yang, Hong-Hai Guo, Yang Liu, Ze Zhang in BMC Cancer (2023)

  11. Article

    Open Access

    Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

    Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relat...

    Cheng Huang, **ao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji in BMC Cancer (2023)

  12. Article

    Open Access

    Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis

    Bone marrow mesenchymal stromal/stem cells (MSCs) are a heterogeneous population that can self-renew and generate stroma, cartilage, fat, and bone. Although a significant progress has been made toward recogniz...

    ** Zhang, Ji Dong, **aoying Fan, Jun Yong in Signal Transduction and Targeted Therapy (2023)

  13. Article

    Open Access

    Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be related to environmental and genetic factors, an...

    Xu Dong-Chen, Chen Yong, Xu Yang in Signal Transduction and Targeted Therapy (2023)

  14. Article

    Open Access

    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC...

    Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang in Signal Transduction and Targeted Therapy (2023)

  15. Article

    Open Access

    Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation

    Excessive inflammatory responses contribute to the pathogenesis and lethality of highly pathogenic human coronaviruses, but the underlying mechanism remains unclear. In this study, the N proteins of highly pat...

    Ting Gao, Lin Zhu, Hainan Liu, **aopeng Zhang in Signal Transduction and Targeted Therapy (2022)

  16. Article

    Open Access

    Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1

    Indoleamine 2,3-dioxygenase 1 (IDO1), the enzyme that catabolizes tryptophan (Trp) metabolism to promote regulatory T cells (Tregs) and suppress CD8+ T cells, is regulated by several intrinsic signaling pathways....

    Fan Liang, Gui-Zhen Wang, Yan Wang in Signal Transduction and Targeted Therapy (2022)

  17. Article

    Open Access

    miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR

    HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acut...

    Yong-**g Tang, Wei Wu, Qiao-Qian Chen, Shu-Han Liu, Zhi-Yuan Zheng in BMC Cancer (2022)

  18. Article

    Open Access

    Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma

    To investigate the maximum tolerated dose (MTD) of apatinib delivered during and after intensity-modulated radiotherapy (IMRT) for unresectable hepatocellular carcinoma (HCC).

    Hongzhi Wang, **anggao Zhu, Yuting Zhao, Dezuo Dong, Lijuan Li, Yong Cai in BMC Cancer (2022)

  19. Article

    Open Access

    Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer

    Ferroptosis is an iron-dependent programmed cell death modality that may have a tumor-suppressive function. Therefore, regulating ferroptosis in tumor cells could serve as a novel therapeutic approach. This ar...

    Jian Hou, Zhenquan Lu, **aobao Cheng, Runan Dong, Yi Jiang, Guoqing Wu in BMC Cancer (2022)

  20. Article

    Open Access

    SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling

    Synovial sarcoma (SS) is a type of soft tissue sarcoma (STS) of undetermined tissue origin, which is characterized by the recurrent pathognomonic chromosomal translocation t (X;18)(p11.2; q11.2). Studies have ...

    Yan Qi, Shuang-Shuang Dong, Yong-Lai He, Zi-Han Liu, Ya-Lan Huang, Ning Wang in BMC Cancer (2022)

previous disabled Page of 4